Related Experiment Video
Updated: May 15, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Fatal spontaneous spinal subdural hematoma in a patient on anticoagulant therapy
Shutaro Nagano1, Yohsuke Makino2, Heather S Jarrell3
1Department of Forensic Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (ST), Tokyo, Japan.
Abstract:
Spinal subdural hematoma (SSDH) is characterized by sudden onset neck and/or back pain, dysuria, and extremity impairment. The use of anticoagulants is a significant risk factor for SSDH, indicating that early diagnosis is crucial. However, achieving a timely diagnosis can be difficult owing to the rarity of this condition. The first forensic autopsy of a patient who died as the result of a spinal subdural hematoma (SSDH) is presented. A woman in her 70s undergoing anticoagulant therapy was transported to the emergency room with headache, back pain, and lower limb paralysis. The patient was initially diagnosed with spondylolisthesis and subsequently went into cardiac arrest. Her autopsy revealed an SSDH extending from the first thoracic vertebra to the cauda equina, with no associated tumors or vascular abnormalities. A retrospective examination of the patient's imaging and clinical history indicated missed opportunities for early diagnosis. The patient's cause of death was determined to be neurogenic shock due to progressive spontaneous SSDH. This case underscores the importance of early diagnosis and treatment of SSDH, particularly in patients undergoing anticoagulant therapy who are at an increased risk of spontaneous SSDH. Although some studies have suggested that conservative treatment may be effective for cases involving mild symptoms, surgical decompression is generally required for those with rapidly worsening symptoms. SSDH, therefore, should be considered in the differential diagnosis of patients presenting with back pain and neurological deficits, as delays in diagnosis and treatment can significantly affect patient outcomes.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

